Use of Glucagon-Like Peptide-1
US$ 23.11
glp-1 agonist names receptor agonists Adverse Effects of GLP-1 Receptor
Description
Understanding their distinct mechanisms, clinical evidence bases, and how genetic and biomarker data inform personalized treatment selection helps patients and providers make evidence-based decisions
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
For external use only
Do not reuse
National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)
